Substance Abuse & Addiction
Top Stories
-
A Columbia study finds that adolescents who use cannabis recreationally are two to four times as likely to develop psychiatric disorders then teens who don’t use cannabis at all.
-
This new series highlights some of the up-and-coming faculty committed to our trifold mission of patient care, medical education, and scientific research.
-
This year’s Eric D. Hadar Distinguished Lecturer, Dr. Rajita Sinha, will present “Can We Rescue Stress and Trauma Related Pathophysiology in Addiction to Improve Treatment Outcomes?” on Nov. 16, 2022.
-
Patients who participate in fewer than two visits early in treatment are at risk for relapse, overdose, and possible death.
Latest News
-
Columbia psychiatrist Nasir Naqvi, MD, PhD, discusses which treatments for alcohol use disorder are most effective and the importance of community and support in treating AUD.
-
Her influential ‘gateway hypothesis’ changed the way we think about addiction.
-
Source:
The New York Times
Jermaine Jones, PhD, a neuroscientist at Columbia, teaches people to rouse individuals experiencing a fentanyl overdose by giving them a firm rub with their knuckles in the center of the chest.
-
Katherine Keyes, director of Columbia’s Psychiatric Epidemiology Training Program, testified at an ongoing trial against three major pharmaceutical companies regarding the opioid epidemic.
-
An opioid addiction vaccine is currently in the first phase of clinical trials, being led by Columbia Psychiatry's Sandra Comer, who directs the university’s Opioid Laboratory.
-
Psychiatrist Carl Fisher discusses his book, The Urge: Our History of Addiction, which interweaves socio-cultural narratives with his experience as a clinician, researcher, and alcoholic in recovery.
-
As more states legalize cannabis for medical or recreational purposes its use during pregnancy is increasing, along with the potential for abuse or dependence.
-
This year’s Eric D. Hadar Lecture will take place on November 3, 2021 with Dr. Steven Shoptaw, who will present, “Medications as Foundation for Stimulant Use Disorder Treatment: Is it Time?”
-
Columbia Psychiatry's Caroline Arout uses quantitative sensory testing, or QST, for assessing the effectiveness of cannabis for therapeutic uses.
-
“Our study provides further evidence that marijuana use is not effective in reducing nonmedical opioid use,” said study author Dr. Mark Olfson.
Pages